Single methyl groups can act as toggle switches to specify transmembrane Protein-protein interactions

Li He, Helena Steinocher, Ashish Shelar, Emily B. Cohen, Erin N. Heim, Birthe B. Kragelund, Gevorg Grigoryan, Daniel DiMaioeLife 2017 · DOI

TL;DR

This study reveals that even minuscule structural changes, like the placement of a single methyl group, can act as "toggle switches" dictating the specificity of protein-protein interactions within cell membranes. By using simplified model proteins, the researchers demonstrate how these subtle differences can precisely control which related receptors are activated, offering new insights into the fundamental rules of membrane protein signaling.

What Problem Does This Paper Address?

Integral membrane proteins, which make up about 30% of our proteome, are crucial for countless cellular functions. Their transmembrane domains (TMDs) are key players in protein-protein interactions that regulate cellular processes. However, understanding why a specific TMD interacts with one partner but not a closely related one has been a major challenge. This lack of understanding hinders our ability to predict and engineer membrane protein behavior. The authors aim to uncover the fundamental principles governing TMD interaction specificity, focusing on the minimal chemical features required for this precise recognition.

Methods

The researchers employed a clever genetic selection system to isolate short, artificial transmembrane proteins called "traptamers." These traptamers were designed to be extremely simple, consisting of only leucine and isoleucine residues (LIL traptamers). This simplification allowed them to isolate the core determinants of specificity. Key techniques included:

  • Genetic Selection: Screening libraries of traptamers for those that could activate the erythropoietin receptor (EPOR) in mammalian cells, leading to growth factor independence.
  • Mutational Analysis: Systematically altering specific amino acids (specifically, swapping leucine and isoleucine) in the traptamers and EPOR TMDs to pinpoint residues critical for interaction and specificity.
  • Biochemical Assays: Using co-immunoprecipitation to confirm physical interactions between traptamers and EPORs.
  • Cellular Assays: Measuring cell proliferation and EPOR/JAK2 phosphorylation to assess biological activity and signaling.
  • NMR Spectroscopy: Investigating the structural effects of traptamer binding on EPOR TMDs in detergent micelles, specifically looking at dimerization.
  • Molecular Dynamics (MD) Simulations: Modeling the conformational landscape of EPOR TMD dimers and how traptamers influence these states, both in implicit and explicit membrane environments.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Methyl Group as a Toggle Switch: The most striking finding is that a single methyl group's position can completely alter a traptamer's specificity, determining whether it interacts with the human EPOR, mouse EPOR, or both. This highlights the exquisite sensitivity of membrane protein interactions to subtle structural changes.
  • Minimal Complexity for Specificity: The study demonstrates that highly specific protein-protein interactions within the membrane can be achieved with remarkably simple sequences (26-residue LIL traptamers), challenging the notion that complex sequences are always required for precise recognition.
  • Shape Complementarity Drives Specificity: The specificity appears to be driven by van der Waals interactions and shape complementarity between the hydrophobic surfaces of the traptamer and the EPOR TMD, rather than specific chemical interactions like hydrogen bonds.
  • EPOR TMD Dictates Response: The TMD sequence of the EPOR itself is the primary determinant of whether a traptamer can activate it, underscoring the importance of this membrane-embedded region.
  • Dynamic Interactions: Molecular dynamics simulations suggest that these interactions are dynamic, with traptamers adopting various orientations while still making specific contacts, leading to a remodeling of the EPOR TMD's conformational landscape.

Key Results

  • Five LIL traptamers were identified that specifically activated the human EPOR (hEPOR) and induced IL-3 independent growth in BaF3 cells.
  • Mutational analysis of traptamer LH5 revealed that swapping a single leucine for isoleucine (or vice versa) at positions 9 or 10 dramatically altered its specificity between hEPOR and mouse EPOR (mEPOR). For example, LH5-L9I specifically activated hEPOR, while LH5-110L specifically activated mEPOR.
  • These traptamer-induced specificities were directly correlated with EPOR tyrosine phosphorylation and JAK2 activation.
  • Chimeric EPOR receptors showed that the EPOR TMD sequence was responsible for mediating traptamer specificity.
  • Co-immunoprecipitation experiments confirmed that active traptamers physically bind to the EPOR TMD.
  • NMR and MD simulations indicated that traptamers induce dimerization of the EPOR TMD and remodel its conformational landscape, favoring states that support signaling.
  • A single amino acid substitution (Ser238 to Leu) in the mEPOR TMD was sufficient to abolish its response to LH5-110L, and conversely, mutating Leu238 in hEPOR to Ser restored sensitivity to LH5-110L.
  • Compensatory mutations in both the traptamer (position 10) and the EPOR TMD (position 238) restored biological activity and complex formation, providing strong genetic evidence for direct interaction.

Limitations and Future Work

  • Stoichiometry Uncertainty: The precise stoichiometry of traptamer-EPOR complexes remains unclear, and simulations suggest it might not be a single, fixed ratio.
  • Functional Relevance of Simulated States: While simulations show traptamers remodel EPOR TMD conformations, the exact functional relevance of these specific states for EPOR activation requires further investigation.
  • Novel Design Principles: The authors suggest that these findings imply entirely novel design principles for modulating TM protein activity, hinting at future work in designing synthetic membrane proteins.
  • Broader Applicability: The principles uncovered with these simplified LIL traptamers are likely applicable to naturally occurring TMDs, suggesting future research could explore how these rules apply to more complex membrane proteins and their interactions.
  • Therapeutic Potential: The ability to precisely modulate TMD interactions with small molecules or peptides opens avenues for developing new therapeutic agents.

Summary updated

Abstract

Transmembrane domains (TMDs) engage in protein-protein interactions that regulate many cellular processes, but the rules governing the specificity of these interactions are poorly understood. To discover these principles, we analyzed 26-residue model transmembrane proteins consisting exclusively of leucine and isoleucine (called LIL traptamers) that specifically activate the erythropoietin receptor (EPOR) in mouse cells to confer growth factor independence. We discovered that the placement of a single side chain methyl group at specific positions in a traptamer determined whether it associated productively with the TMD of the human EPOR, the mouse EPOR, or both receptors. Association of the traptamers with the EPOR induced EPOR oligomerization in an orientation that stimulated receptor activity. These results highlight the high intrinsic specificity of TMD interactions, demonstrate that a single methyl group can dictate specificity, and define the minimal chemical difference that can modulate the specificity of TMD interactions and the activity of transmembrane proteins.
BibTeX
@inproceedings{he2017single,
  author = {Li He and Helena Steinocher and Ashish Shelar and Emily B. Cohen and Erin N. Heim and Birthe B. Kragelund and Gevorg Grigoryan and Daniel DiMaio},
  title = {{Single methyl groups can act as toggle switches to specify transmembrane Protein-protein interactions}},
  booktitle = {eLife},
  year = {2017},
  doi = {10.7554/elife.27701},
}
Figure